JP2005508893A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508893A5
JP2005508893A5 JP2003522551A JP2003522551A JP2005508893A5 JP 2005508893 A5 JP2005508893 A5 JP 2005508893A5 JP 2003522551 A JP2003522551 A JP 2003522551A JP 2003522551 A JP2003522551 A JP 2003522551A JP 2005508893 A5 JP2005508893 A5 JP 2005508893A5
Authority
JP
Japan
Prior art keywords
fucan
pharmaceutical composition
use according
effective amount
therapeutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003522551A
Other languages
English (en)
Japanese (ja)
Other versions
JP4758063B2 (ja
JP2005508893A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2002/001337 external-priority patent/WO2003018033A1/en
Publication of JP2005508893A publication Critical patent/JP2005508893A/ja
Publication of JP2005508893A5 publication Critical patent/JP2005508893A5/ja
Application granted granted Critical
Publication of JP4758063B2 publication Critical patent/JP4758063B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003522551A 2001-08-29 2002-08-29 癒着、関節炎及び乾癬の治療へのフカン類の使用 Expired - Lifetime JP4758063B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31536201P 2001-08-29 2001-08-29
US60/315,362 2001-08-29
PCT/CA2002/001337 WO2003018033A1 (en) 2001-08-29 2002-08-29 Use of fucans in the treatment of adhesions, arthritis and psoriasis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009170270A Division JP2009280597A (ja) 2001-08-29 2009-07-21 乾癬の治療へのフカン類の使用

Publications (3)

Publication Number Publication Date
JP2005508893A JP2005508893A (ja) 2005-04-07
JP2005508893A5 true JP2005508893A5 (cg-RX-API-DMAC7.html) 2006-01-05
JP4758063B2 JP4758063B2 (ja) 2011-08-24

Family

ID=23224048

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003522551A Expired - Lifetime JP4758063B2 (ja) 2001-08-29 2002-08-29 癒着、関節炎及び乾癬の治療へのフカン類の使用
JP2009170270A Withdrawn JP2009280597A (ja) 2001-08-29 2009-07-21 乾癬の治療へのフカン類の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009170270A Withdrawn JP2009280597A (ja) 2001-08-29 2009-07-21 乾癬の治療へのフカン類の使用

Country Status (15)

Country Link
US (3) US6812220B2 (cg-RX-API-DMAC7.html)
EP (1) EP1420801B1 (cg-RX-API-DMAC7.html)
JP (2) JP4758063B2 (cg-RX-API-DMAC7.html)
KR (2) KR100910246B1 (cg-RX-API-DMAC7.html)
CN (2) CN101028283A (cg-RX-API-DMAC7.html)
AT (1) ATE376835T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002325113B2 (cg-RX-API-DMAC7.html)
CA (1) CA2458853C (cg-RX-API-DMAC7.html)
DE (1) DE60223262T2 (cg-RX-API-DMAC7.html)
DK (1) DK1420801T3 (cg-RX-API-DMAC7.html)
ES (1) ES2295386T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA04001876A (cg-RX-API-DMAC7.html)
NZ (2) NZ532015A (cg-RX-API-DMAC7.html)
PT (1) PT1420801E (cg-RX-API-DMAC7.html)
WO (1) WO2003018033A1 (cg-RX-API-DMAC7.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632456B1 (en) * 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
SI1539157T1 (sl) * 2002-09-18 2013-11-29 Trustees Of The University Of Pennsylvania Rapamicin za uporabo pri inhibiciji ali preprečevanju horoidalne neovaskularizacije
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8221758B2 (en) * 2003-03-06 2012-07-17 Cellmid Limited Anti-midkine antibody for preventing post-laparotomy adhesions
EP1631265A2 (en) * 2003-05-30 2006-03-08 Arc Pharmaceuticals, Inc. Use of various agents for inhibiting fibrous adhesions
JP2007505932A (ja) 2003-09-18 2007-03-15 マクサイト, インコーポレイテッド 経強膜送達
JPWO2005089800A1 (ja) * 2004-03-17 2008-01-31 株式会社ロコモジェン hsHRD3を含む医薬組成物
CA2572804C (en) * 2004-07-09 2013-04-02 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
WO2006032143A1 (en) 2004-09-23 2006-03-30 Arc Pharmaceuticals, Inc. Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
CA2597590A1 (en) 2005-02-09 2006-08-17 Macusight, Inc. Formulations for ocular treatment
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
KR100752244B1 (ko) * 2005-02-16 2007-08-27 주식회사 엠디바이오알파 비만, 당뇨, 대사성 질환, 퇴행성 질환 및 미토콘드리아이상 질환의 치료 또는 예방을 위한 약제 조성물
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US20060210514A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin protection and moisturizing compositions and method of making the same
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US7749545B2 (en) 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US7666448B2 (en) * 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
DK1871353T3 (da) 2005-04-15 2011-04-04 Einstein Coll Med Vitamin k til forebyggelse eller behandling af hududslæt sekundært til anti-EGFR-terapi
US20070003669A1 (en) * 2005-06-02 2007-01-04 Troy Kearl Fucoidan delivery system
WO2007028256A2 (en) * 2005-09-09 2007-03-15 Les Biotechnologies Oceanova Inc. Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
KR101478164B1 (ko) 2006-02-09 2014-12-31 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
FR2897538B1 (fr) 2006-02-23 2008-05-02 Univ Paris Descartes Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses
AU2007230964B2 (en) 2006-03-23 2012-07-19 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
JP4814677B2 (ja) * 2006-03-31 2011-11-16 株式会社荏原製作所 基板保持装置および研磨装置
US9428582B2 (en) 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
ES2585483T3 (es) 2008-02-13 2016-10-06 The Cleveland Clinic Foundation Mejora molecular de la matriz extracelular y métodos de uso
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
US8410180B2 (en) 2008-04-30 2013-04-02 The Cleveland Clinic Foundation Methods to treat urinary incontinence
WO2010109736A1 (ja) * 2009-03-25 2010-09-30 国立大学法人鳥取大学 軟骨生成促進剤および軟骨損傷由来疾病の予防治療剤
JO3676B1 (ar) * 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
KR101528265B1 (ko) * 2010-04-16 2015-06-11 코웨이 주식회사 베타-라파콘을 유효성분으로 포함하는 주름개선용 화장료 조성물
EP2734213B1 (en) * 2011-07-19 2018-06-06 Baxalta GmbH Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
JP2018510905A (ja) * 2015-02-16 2018-04-19 エグザンシャル 皮膚障害の予防又は治療のための組成物
PT3448421T (pt) * 2016-04-29 2022-01-14 Univ Leland Stanford Junior Métodos e composições para a prevenção e tratamento de aderências cirúrgicas
US12186334B2 (en) 2018-07-27 2025-01-07 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
MX2021000864A (es) 2018-07-27 2021-03-26 Arc Medical Devices Inc Fucanos altos en sulfato para el tratamiento de adhesiones fibrosas.
AU2020230466B2 (en) 2019-03-05 2021-05-13 Arc Medical Devices Inc. Systems and methods for tangential flow filtration of viscous compositions
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用
WO2025166450A1 (en) * 2024-02-05 2025-08-14 ARC Medical Inc. Compositions, devices, systems and methods relating to improvement of range of motion in joints

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971848A (en) * 1970-12-21 1976-07-27 Kimitsu Chemical Laboratory Co. Ltd. Lubricating composition for mucosa or epidermis
JPS58147064A (ja) 1982-02-25 1983-09-01 Fuji Electric Co Ltd トランジスタ
EP0293826A3 (en) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
JPS6431707A (en) 1987-07-28 1989-02-02 Nikko Chemicals Dermal agent for external use
JPH0714850B2 (ja) 1987-09-29 1995-02-22 喜郎 板谷 化粧料
JPH01313433A (ja) 1988-06-13 1989-12-18 Nippon Koutai Kenkyusho:Kk 抗hiv剤
JP2853165B2 (ja) * 1989-05-29 1999-02-03 味の素株式会社 体組織癒着防止膜
FR2648463B1 (fr) * 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention
US6096722A (en) * 1990-08-14 2000-08-01 Isis Pharmaceuticals Inc. Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JP3403496B2 (ja) 1993-09-24 2003-05-06 株式会社ヤクルト本社 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤
JP3545789B2 (ja) * 1993-09-30 2004-07-21 味の素ファルマ株式会社 腹腔内癒着防止剤
FR2772618B1 (fr) * 1997-12-18 2000-02-18 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
JP2002526556A (ja) * 1998-10-02 2002-08-20 ジェンザイム・コーポレーション 癒着の防止方法
JP4267106B2 (ja) * 1998-10-15 2009-05-27 株式会社クラレ 癒着防止用材料
JP2001052309A (ja) 1999-08-06 2001-02-23 Alps Electric Co Ltd 薄膜磁気ヘッドおよびその製造方法
SE0001631D0 (sv) * 2000-05-04 2000-05-04 Sahltech Ab New use

Similar Documents

Publication Publication Date Title
CA2458853A1 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
Mao et al. Targeted treatment for osteoarthritis: drugs and delivery system
JP6770157B2 (ja) 特定の投薬量の活性物質を皮膚又は粘膜に投与するための電気流体力学的に得られた繊維を含む組成物
JP6929916B2 (ja) 適用部位における滞留時間が改善された、電気流体力学的に得られた繊維を含む医薬組成物
JP3964465B2 (ja) 粘膜表面への、薬学的化合物の送達に適する薬学的キャリアデバイス
Riccio et al. Exploiting polymeric films as a multipurpose drug delivery system: a review
US9498431B2 (en) Controlled releasing composition
WO2001064214A2 (en) Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
US8475823B2 (en) Baclofen formulation in a polyorthoester carrier
JP2005527535A5 (cg-RX-API-DMAC7.html)
JP2008537695A (ja) 副鼻腔の症状を治療するための装置および方法
US20220168465A1 (en) Biodegradable nasal splint
CN103263413B (zh) 一种酮咯酸植入剂及其制备方法
JP2026503608A (ja) 変形性関節症などの関節疾患の治療に使用するためのコルヒチンを含む関節内注射用剤形
EP2889030A1 (en) Controlling the erosion rates of mucoadhesive devices that deliver actives and other compounds and providing increased and variable therapeutic blood levels
KR100885178B1 (ko) 점착성 약제 조성물
US20230225963A1 (en) Thermogel sustained-release microparticle-based delivery to a paranasal and/or nasal cavity
JP2026512647A (ja) 結晶および非結晶に関連づけられた急性炎症性関節炎の治療におけるコルヒチンおよび麻酔剤を含む関節内注射用剤形
Hama et al. Nanocarriers for controlled drug delivery A convergence of polymer and nanochemistry
Liu et al. Orthopedic implants of ketorolac in vertebral fracture: Development, physicochemical, preclinical and clinical evaluation
Gul et al. Emerging role of chondroitin sulfate based nanocarriers in improving the therapeutic outcome of NSAIDs in the treatment of osteoarthritis through the TDDDS
Sonawane et al. Review on mucoadhesive drug delivery system
Yehia et al. Advanced biodegradable-based formulations for the treatment of arthritis
Magbool et al. African Journal of Pharmaceutical Sciences
Baldha et al. Biodegradable Polymers and Long‐Acting Parenteral Formulations: An Overview